Shin, Sheojung
Whitmore, George Alex
Boulet, Louis-Philippe
Boulay, Marie-Ève
Côté, Andréanne
Bergeron, Céline
Lemière, Catherine
Lougheed, M. Diane
Vandemheen, Katherine L.
Alvarez, Gonzalo G.
Mulpuru, Sunita
Aaron, Shawn D.
Article History
Received: 27 August 2023
Accepted: 5 December 2023
First Online: 9 December 2023
Declarations
:
: Before study initiation, this study was approved by the Ottawa Health Science Network Research Ethics Board (Reference No. 2017–0182-01H), Clinical Trials Ontario (Reference No. 1357), Vancouver Coastal Health Research Authority (Reference No. H17–03087) and Centre intégré universitaire de santé et de services sociaux du Nord-de-I’lle-de -Montreal (Reference No. MP-32-2018-1548) for the protocol, consent, study materials, study process. All participants provided informed written consent to participate and for publication.
: SS has nothing to disclose.GAW has nothing to disclose.LPB has grants from Amgen, AstraZeneca, Glaxo SmithKline, Merck, Novartis, and Sanofi-Regeneron for participation to multicenter studies and research projects proposed by the investigator; royalties from UptoDate and Taylor and Francis; lecture fees from AstraZeneca, Covis, Glaxo SmithKline, Novartis, Merck and Sanofi; is chair of the Global initiative for Asthma (GINA) board of directors, president of the Global Asthma Organisation (Interasma), holder of the Laval University Chair on Knowledge Transferm prevention and Education in respiratory and Cardiovascular Health membership on the Canadian Thoracic Society Respiratory Guidelines Committee;MEB has nothing to disclose.AC has research grants from Glaxo SmithKline; speakers fees from AstraZeneca, Glaxo SmithKline, Valeo and Sanofi; participation to advisory boards for Glaxo SmithKline, AstraZeneca, Sanofi, Valeo.CB reports consulting fees from Sanofi, AstraZeneca and Takeda; payments for presentations from Grifols, AstraZeneca, Sanofi and Valeo.CL has royalties from UptoDate, consulting fees from Glaxo SmithKline, AstraZeneca and Sanofi; payments for presentations from Glaxo SmithKline, AstraZeneca and Sanofi.MDL received grants from the Manitoba Workers Compensation Board, the Ontario Lung Association, the Ontario Thoracic Society, the Government of Ontario’s Innovation Fund, Queen’s University, European Respiratory Journal AstraZeneca and Glaxo SmithKline; payments for co-development and co-presentation of a severe asthma preparation course from the Canadian Thoracic Society and for co-development of an accredited CME module on severe asthma from MDBriefcase; participation on advisory board from AstraZeneca; membership on the Canadian Thoracic Society Asthma Clinical Assembly and Canadian Thoracic Society Asthma Clinical Assembly Steering Committee, Health Quality Ontario’s Asthma in Adults and Asthma in Children Quality Standard Advisory Committee; is past chair of the Canadian Thoracic Society Asthma Clinical Assembly, is a Canadian Thoracic Society representative on the Lung Association’s Board of Directors and a Canadian Thoracic Society representative to the European Respiratory Society.KLV has nothing to disclose.GGA has nothing to disclose.SM has nothing to disclose.SDA reports payments for lectures from AstraZeneca, Glaxo SmithKline and Sanofi; participation on advisory boards for AstraZeneca, Glaxo SmithKline, Sanofi and Covis.